cancer_type qtl_type tag_SNP LD SNP_id gene_id gene_symbol t-stat p-value beta r Traits SNP_position Gene_position PAAD cis rs75358501 0.688 rs2287629 MIMAT0014995 hsa-miR-3130-5p 15.39 6.96e-33 0.97 0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783276~206783296:- PAAD cis rs75358501 0.688 rs2287629 MIMAT0014995_1 hsa-miR-3130-5p 15.39 6.96e-33 0.97 0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs12471008 MIMAT0014995 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs12471008 MIMAT0014995_1 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs768533 MIMAT0014995 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs768533 MIMAT0014995_1 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs13427002 MIMAT0014995 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs13427002 MIMAT0014995_1 hsa-miR-3130-5p -15.25 1.6e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs2241347 MIMAT0014995 hsa-miR-3130-5p -15.22 1.89e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs2241347 MIMAT0014995_1 hsa-miR-3130-5p -15.22 1.89e-32 -0.96 -0.78 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs725980 MIMAT0014995 hsa-miR-3130-5p -14.95 1.02e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs725980 MIMAT0014995_1 hsa-miR-3130-5p -14.95 1.02e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs10199766 MIMAT0014995 hsa-miR-3130-5p -14.95 1.02e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs10199766 MIMAT0014995_1 hsa-miR-3130-5p -14.95 1.02e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs7576591 MIMAT0014995 hsa-miR-3130-5p -14.92 1.2e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs7576591 MIMAT0014995_1 hsa-miR-3130-5p -14.92 1.2e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs2287628 MIMAT0014995 hsa-miR-3130-5p -14.92 1.2e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs2287628 MIMAT0014995_1 hsa-miR-3130-5p -14.92 1.2e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs888621 MIMAT0014995 hsa-miR-3130-5p 14.92 1.2e-31 0.94 0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs888621 MIMAT0014995_1 hsa-miR-3130-5p 14.92 1.2e-31 0.94 0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs957414 MIMAT0014995 hsa-miR-3130-5p -14.84 1.93e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206800861 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs957414 MIMAT0014995_1 hsa-miR-3130-5p -14.84 1.93e-31 -0.95 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206800861 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs11895370 MIMAT0014995 hsa-miR-3130-5p -14.73 3.95e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs11895370 MIMAT0014995_1 hsa-miR-3130-5p -14.73 3.95e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs4673363 MIMAT0014995 hsa-miR-3130-5p -14.7 4.7e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206804687 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs4673363 MIMAT0014995_1 hsa-miR-3130-5p -14.7 4.7e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206804687 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs57600974 MIMAT0014995 hsa-miR-3130-5p -14.7 4.7e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206805471 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs57600974 MIMAT0014995_1 hsa-miR-3130-5p -14.7 4.7e-31 -0.94 -0.77 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206805471 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs12478466 MIMAT0014995 hsa-miR-3130-5p -14.54 1.21e-30 -0.94 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206806288 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs12478466 MIMAT0014995_1 hsa-miR-3130-5p -14.54 1.21e-30 -0.94 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206806288 chr2:206783246~206783266:+ PAAD cis rs75358501 0.688 rs28365797 MIMAT0014995 hsa-miR-3130-5p -14.53 1.29e-30 -0.92 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765122 chr2:206783276~206783296:- PAAD cis rs75358501 0.688 rs28365797 MIMAT0014995_1 hsa-miR-3130-5p -14.53 1.29e-30 -0.92 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765122 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs16838834 MIMAT0014995 hsa-miR-3130-5p -14.37 3.43e-30 -0.91 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs16838834 MIMAT0014995_1 hsa-miR-3130-5p -14.37 3.43e-30 -0.91 -0.76 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs3815686 MIMAT0014995 hsa-miR-3130-5p -13.82 1.03e-28 -0.91 -0.75 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs3815686 MIMAT0014995_1 hsa-miR-3130-5p -13.82 1.03e-28 -0.91 -0.75 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783246~206783266:+ PAAD cis rs75358501 0.584 rs11894165 MIMAT0014995 hsa-miR-3130-5p -12.93 2.63e-26 -0.93 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783276~206783296:- PAAD cis rs75358501 0.584 rs11894165 MIMAT0014995_1 hsa-miR-3130-5p -12.93 2.63e-26 -0.93 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783246~206783266:+ PAAD cis rs75358501 0.688 rs1862087 MIMAT0014995 hsa-miR-3130-5p -12.93 2.63e-26 -0.93 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783276~206783296:- PAAD cis rs75358501 0.688 rs1862087 MIMAT0014995_1 hsa-miR-3130-5p -12.93 2.63e-26 -0.93 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs1862089 MIMAT0014995 hsa-miR-3130-5p -12.19 2.64e-24 -0.91 -0.7 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs1862089 MIMAT0014995_1 hsa-miR-3130-5p -12.19 2.64e-24 -0.91 -0.7 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs7580138 MIMAT0014995 hsa-miR-3130-5p -11.96 1.08e-23 -0.9 -0.7 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs7580138 MIMAT0014995_1 hsa-miR-3130-5p -11.96 1.08e-23 -0.9 -0.7 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783246~206783266:+ PAAD cis rs75358501 0.636 rs10932164 MIMAT0014995 hsa-miR-3130-5p -11.85 2.13e-23 -0.91 -0.69 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783276~206783296:- PAAD cis rs75358501 0.636 rs10932164 MIMAT0014995_1 hsa-miR-3130-5p -11.85 2.13e-23 -0.91 -0.69 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783246~206783266:+ PAAD cis rs6841433 0.848 rs13328022 MIMAT0003242 hsa-miR-577 11.45 2.51e-22 1 0.68 Hemoglobin concentration; chr4:114700701 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs34403669 MIMAT0003242 hsa-miR-577 11.45 2.51e-22 1 0.68 Hemoglobin concentration; chr4:114703735 chr4:114656774~114656794:+ PAAD cis rs6841433 0.948 rs7671477 MIMAT0003242 hsa-miR-577 11.25 8.68e-22 1.04 0.67 Hemoglobin concentration; chr4:114632518 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs7677294 MIMAT0003242 hsa-miR-577 11.19 1.27e-21 1.04 0.67 Hemoglobin concentration; chr4:114633283 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs6841433 MIMAT0003242 hsa-miR-577 11.03 3.4e-21 0.98 0.67 Hemoglobin concentration; chr4:114647874 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs6533803 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114637085 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs10049660 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114637758 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs35271056 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114642195 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs10011293 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114656225 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs35217170 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114672701 chr4:114656774~114656794:+ PAAD cis rs6841433 0.948 rs13135834 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114678835 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs28390138 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114687320 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs6828127 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114689927 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs55875005 MIMAT0003242 hsa-miR-577 11 4.26e-21 0.98 0.66 Hemoglobin concentration; chr4:114691920 chr4:114656774~114656794:+ PAAD cis rs6841433 0.948 rs9884805 MIMAT0003242 hsa-miR-577 10.96 5.24e-21 0.98 0.66 Hemoglobin concentration; chr4:114697040 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs34115976 MIMAT0003242 hsa-miR-577 10.96 5.3e-21 0.99 0.66 Hemoglobin concentration; chr4:114656841 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs13133899 MIMAT0003242 hsa-miR-577 10.96 5.3e-21 0.99 0.66 Hemoglobin concentration; chr4:114661153 chr4:114656774~114656794:+ PAAD cis rs6841433 0.948 rs35736852 MIMAT0003242 hsa-miR-577 10.96 5.3e-21 0.99 0.66 Hemoglobin concentration; chr4:114687255 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs34546485 MIMAT0003242 hsa-miR-577 10.93 6.45e-21 0.99 0.66 Hemoglobin concentration; chr4:114693882 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs13133286 MIMAT0003242 hsa-miR-577 10.93 6.45e-21 0.99 0.66 Hemoglobin concentration; chr4:114701654 chr4:114656774~114656794:+ PAAD cis rs6841433 0.948 rs34110012 MIMAT0003242 hsa-miR-577 10.93 6.45e-21 0.99 0.66 Hemoglobin concentration; chr4:114710498 chr4:114656774~114656794:+ PAAD cis rs6841433 1 rs10008981 MIMAT0003242 hsa-miR-577 10.93 6.54e-21 0.98 0.66 Hemoglobin concentration; chr4:114650189 chr4:114656774~114656794:+ PAAD cis rs6841433 0.706 rs13147491 MIMAT0003242 hsa-miR-577 10.64 3.78e-20 1.18 0.65 Hemoglobin concentration; chr4:114696462 chr4:114656774~114656794:+ PAAD cis rs6841433 0.706 rs13134858 MIMAT0003242 hsa-miR-577 10.54 7.19e-20 1.2 0.65 Hemoglobin concentration; chr4:114601150 chr4:114656774~114656794:+ PAAD cis rs6841433 0.706 rs35571359 MIMAT0003242 hsa-miR-577 10.54 7.19e-20 1.2 0.65 Hemoglobin concentration; chr4:114606130 chr4:114656774~114656794:+ PAAD cis rs6841433 0.706 rs35759252 MIMAT0003242 hsa-miR-577 10.52 8.1e-20 1.2 0.65 Hemoglobin concentration; chr4:114608520 chr4:114656774~114656794:+ PAAD cis rs75358501 0.748 rs12470963 MIMAT0014995 hsa-miR-3130-5p -9.6 2.22e-17 -0.84 -0.61 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206774869 chr2:206783276~206783296:- PAAD cis rs75358501 0.748 rs12470963 MIMAT0014995_1 hsa-miR-3130-5p -9.6 2.22e-17 -0.84 -0.61 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206774869 chr2:206783246~206783266:+ PAAD cis rs6841433 0.615 rs13114989 MIMAT0003242 hsa-miR-577 9.32 1.25e-16 1.02 0.6 Hemoglobin concentration; chr4:114538869 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs6849357 MIMAT0003242 hsa-miR-577 -9.22 2.25e-16 -1 -0.6 Hemoglobin concentration; chr4:114598115 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13112553 MIMAT0003242 hsa-miR-577 -9.22 2.25e-16 -1 -0.6 Hemoglobin concentration; chr4:114598194 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12511581 MIMAT0003242 hsa-miR-577 -9.22 2.25e-16 -1 -0.6 Hemoglobin concentration; chr4:114598400 chr4:114656774~114656794:+ PAAD cis rs6841433 0.516 rs11098259 MIMAT0003242 hsa-miR-577 -9.22 2.25e-16 -1 -0.6 Hemoglobin concentration; chr4:114598669 chr4:114656774~114656794:+ PAAD cis rs6841433 0.56 rs11098260 MIMAT0003242 hsa-miR-577 -9.22 2.25e-16 -1 -0.6 Hemoglobin concentration; chr4:114598670 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12641516 MIMAT0003242 hsa-miR-577 9.15 3.37e-16 1 0.59 Hemoglobin concentration; chr4:114556972 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs17047201 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114544945 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13127912 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114546019 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs10516604 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114546112 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs10516603 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114546303 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13135560 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114547331 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35777558 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114548111 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs34685786 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114549280 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs79776742 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114550195 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs57059575 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114551237 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13147106 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114552206 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13147485 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114552321 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13120552 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114552518 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13101831 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114552771 chr4:114656774~114656794:+ PAAD cis rs6841433 0.66 rs13127941 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114553520 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13147198 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114553935 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35594431 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114554497 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs34403145 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114554629 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12643074 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114555226 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs2100783 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114555821 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35252674 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114556583 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs71606719 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114557814 chr4:114656774~114656794:+ PAAD cis rs6841433 0.511 rs13125495 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114558326 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12650115 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114560232 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12644238 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114560598 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs1903365 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114561897 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13110751 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114563572 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13105144 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114563873 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs13129837 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114563925 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs33914856 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114564668 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs1380932 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114565923 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35082726 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114566777 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs17047238 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114568870 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13144260 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114573271 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs34948407 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114575280 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs56149980 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114576580 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12642541 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114579576 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs57930571 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114580433 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35732213 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114581427 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35936834 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114581520 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs6813229 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114582721 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs6813283 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114582806 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs6839189 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114582848 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs35789595 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114594055 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs35578985 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114594500 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs34001486 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114594792 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs7437576 MIMAT0003242 hsa-miR-577 9.12 3.93e-16 0.99 0.59 Hemoglobin concentration; chr4:114595467 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12648803 MIMAT0003242 hsa-miR-577 -9.12 3.93e-16 -0.99 -0.59 Hemoglobin concentration; chr4:114546228 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs7434753 MIMAT0003242 hsa-miR-577 9.12 4.16e-16 1 0.59 Hemoglobin concentration; chr4:114596387 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs17047239 MIMAT0003242 hsa-miR-577 9.1 4.46e-16 0.93 0.59 Hemoglobin concentration; chr4:114570559 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs17047244 MIMAT0003242 hsa-miR-577 9.1 4.46e-16 0.93 0.59 Hemoglobin concentration; chr4:114571532 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs17047246 MIMAT0003242 hsa-miR-577 9.1 4.46e-16 0.93 0.59 Hemoglobin concentration; chr4:114571876 chr4:114656774~114656794:+ PAAD cis rs6841433 0.687 rs12640227 MIMAT0003242 hsa-miR-577 -9.06 5.7e-16 -0.81 -0.59 Hemoglobin concentration; chr4:114700788 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs79261962 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114539953 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs77422558 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114540944 chr4:114656774~114656794:+ PAAD cis rs6841433 0.571 rs12649041 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114541220 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs13136602 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114541864 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12649943 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114542460 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs12649963 MIMAT0003242 hsa-miR-577 9.05 6.09e-16 1 0.59 Hemoglobin concentration; chr4:114542537 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs17047198 MIMAT0003242 hsa-miR-577 9.05 6.22e-16 0.99 0.59 Hemoglobin concentration; chr4:114544338 chr4:114656774~114656794:+ PAAD cis rs6841433 0.904 rs11731984 MIMAT0003242 hsa-miR-577 -8.92 1.37e-15 -0.84 -0.58 Hemoglobin concentration; chr4:114663873 chr4:114656774~114656794:+ PAAD cis rs6841433 0.615 rs17047236 MIMAT0003242 hsa-miR-577 8.88 1.65e-15 0.96 0.58 Hemoglobin concentration; chr4:114564575 chr4:114656774~114656794:+ PAAD cis rs6841433 0.699 rs12643031 MIMAT0003242 hsa-miR-577 8.65 6.41e-15 0.84 0.57 Hemoglobin concentration; chr4:114541449 chr4:114656774~114656794:+ PAAD cis rs6841433 0.607 rs34695716 MIMAT0003242 hsa-miR-577 -8.56 1.13e-14 -0.79 -0.57 Hemoglobin concentration; chr4:114658285 chr4:114656774~114656794:+ PAAD cis rs6841433 0.718 rs7656139 MIMAT0003242 hsa-miR-577 -8.56 1.13e-14 -0.79 -0.57 Hemoglobin concentration; chr4:114672622 chr4:114656774~114656794:+ PAAD cis rs6841433 0.75 rs6857337 MIMAT0003242 hsa-miR-577 8.56 1.13e-14 0.79 0.57 Hemoglobin concentration; chr4:114667805 chr4:114656774~114656794:+ PAAD cis rs6841433 0.511 rs34534063 MIMAT0003242 hsa-miR-577 7.5 4.77e-12 0.79 0.52 Hemoglobin concentration; chr4:114538077 chr4:114656774~114656794:+ PAAD cis rs6841433 0.511 rs36078253 MIMAT0003242 hsa-miR-577 7.5 4.77e-12 0.79 0.52 Hemoglobin concentration; chr4:114538112 chr4:114656774~114656794:+ PAAD cis rs6841433 0.632 rs6533807 MIMAT0003242 hsa-miR-577 -7.25 1.96e-11 -0.64 -0.51 Hemoglobin concentration; chr4:114699454 chr4:114656774~114656794:+ PAAD cis rs7894407 0.634 rs755577 MIMAT0005951 hsa-miR-1307-3p 7.07 5.05e-11 0.41 0.5 White matter hyperintensity burden; chr10:103464309 chr10:103394301~103394322:- PAAD cis rs6841433 0.632 rs13106767 MIMAT0003242 hsa-miR-577 -7.05 5.88e-11 -0.62 -0.49 Hemoglobin concentration; chr4:114635719 chr4:114656774~114656794:+ PAAD cis rs6841433 0.632 rs35717197 MIMAT0003242 hsa-miR-577 -7.05 5.88e-11 -0.62 -0.49 Hemoglobin concentration; chr4:114639584 chr4:114656774~114656794:+ PAAD cis rs6841433 0.632 rs13152031 MIMAT0003242 hsa-miR-577 -7.05 5.88e-11 -0.62 -0.49 Hemoglobin concentration; chr4:114644503 chr4:114656774~114656794:+ PAAD cis rs6841433 0.632 rs7679995 MIMAT0003242 hsa-miR-577 -7.05 5.88e-11 -0.62 -0.49 Hemoglobin concentration; chr4:114665137 chr4:114656774~114656794:+ PAAD cis rs6841433 0.561 rs13148598 MIMAT0003242 hsa-miR-577 -7.05 5.88e-11 -0.62 -0.49 Hemoglobin concentration; chr4:114676939 chr4:114656774~114656794:+ PAAD cis rs1712517 0.873 rs1163086 MIMAT0005951 hsa-miR-1307-3p -6.97 8.73e-11 -0.36 -0.49 Migraine; chr10:103279822 chr10:103394301~103394322:- PAAD cis rs6841433 0.632 rs4834428 MIMAT0003242 hsa-miR-577 -6.96 9.57e-11 -0.61 -0.49 Hemoglobin concentration; chr4:114683908 chr4:114656774~114656794:+ PAAD cis rs1712517 0.873 rs1712516 MIMAT0005951 hsa-miR-1307-3p -6.94 1.05e-10 -0.36 -0.49 Migraine; chr10:103273871 chr10:103394301~103394322:- PAAD cis rs1712517 0.503 rs72846198 MIMAT0005951 hsa-miR-1307-3p -6.84 1.75e-10 -0.39 -0.48 Migraine; chr10:103338267 chr10:103394301~103394322:- PAAD cis rs1712517 0.566 rs7076274 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103286250 chr10:103394301~103394322:- PAAD cis rs1712517 0.545 rs3740381 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103286932 chr10:103394301~103394322:- PAAD cis rs1712517 0.566 rs7917388 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103295206 chr10:103394301~103394322:- PAAD cis rs1712517 0.525 rs11191642 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103296155 chr10:103394301~103394322:- PAAD cis rs1712517 0.588 rs12220267 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103315955 chr10:103394301~103394322:- PAAD cis rs1712517 0.526 rs113528138 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103365694 chr10:103394301~103394322:- PAAD cis rs1712517 0.525 rs11191667 MIMAT0005951 hsa-miR-1307-3p -6.79 2.39e-10 -0.38 -0.48 Migraine; chr10:103369141 chr10:103394301~103394322:- PAAD cis rs1712517 0.525 rs7911488 MIMAT0005951 hsa-miR-1307-3p -6.74 3.09e-10 -0.38 -0.48 Migraine; chr10:103394332 chr10:103394301~103394322:- PAAD cis rs1712517 0.524 rs1712509 MIMAT0005951 hsa-miR-1307-3p -6.73 3.21e-10 -0.38 -0.48 Migraine; chr10:103254113 chr10:103394301~103394322:- PAAD cis rs1712517 0.787 rs1163089 MIMAT0005951 hsa-miR-1307-3p -6.72 3.4e-10 -0.36 -0.48 Migraine; chr10:103284207 chr10:103394301~103394322:- PAAD cis rs1712517 0.844 rs1163087 MIMAT0005951 hsa-miR-1307-3p -6.69 3.92e-10 -0.36 -0.48 Migraine; chr10:103283532 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs7913461 MIMAT0005951 hsa-miR-1307-3p -6.67 4.28e-10 -0.35 -0.47 Migraine; chr10:103241568 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs7916056 MIMAT0005951 hsa-miR-1307-3p 6.67 4.49e-10 0.35 0.47 Migraine; chr10:103238157 chr10:103394301~103394322:- PAAD cis rs75358501 0.901 rs76270461 MIMAT0014995 hsa-miR-3130-5p -6.66 4.72e-10 -0.8 -0.47 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783276~206783296:- PAAD cis rs75358501 0.901 rs76270461 MIMAT0014995_1 hsa-miR-3130-5p -6.66 4.72e-10 -0.8 -0.47 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783246~206783266:+ PAAD cis rs75358501 0.901 rs79499040 MIMAT0014995 hsa-miR-3130-5p -6.6 6.4e-10 -0.8 -0.47 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783276~206783296:- PAAD cis rs75358501 0.901 rs79499040 MIMAT0014995_1 hsa-miR-3130-5p -6.6 6.4e-10 -0.8 -0.47 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783246~206783266:+ PAAD cis rs4917385 1 rs4917385 MIMAT0005951 hsa-miR-1307-3p 6.59 6.54e-10 0.37 0.47 Systemic lupus erythematosus; chr10:103243964 chr10:103394301~103394322:- PAAD cis rs1712517 0.524 rs4917384 MIMAT0005951 hsa-miR-1307-3p 6.47 1.27e-09 0.37 0.46 Migraine; chr10:103236031 chr10:103394301~103394322:- PAAD cis rs1712517 0.525 rs2271751 MIMAT0005951 hsa-miR-1307-3p -6.42 1.64e-09 -0.36 -0.46 Migraine; chr10:103415374 chr10:103394301~103394322:- PAAD cis rs1712517 0.773 rs1063461 MIMAT0005951 hsa-miR-1307-3p -6.38 1.95e-09 -0.34 -0.46 Migraine; chr10:103289348 chr10:103394301~103394322:- PAAD cis rs1712517 0.74 rs4293062 MIMAT0005951 hsa-miR-1307-3p -6.38 1.95e-09 -0.34 -0.46 Migraine; chr10:103292867 chr10:103394301~103394322:- PAAD cis rs1712517 0.744 rs11191641 MIMAT0005951 hsa-miR-1307-3p -6.38 1.95e-09 -0.34 -0.46 Migraine; chr10:103293183 chr10:103394301~103394322:- PAAD cis rs1712517 0.744 rs4293063 MIMAT0005951 hsa-miR-1307-3p -6.38 1.95e-09 -0.34 -0.46 Migraine; chr10:103293219 chr10:103394301~103394322:- PAAD cis rs1712517 0.844 rs1163074 MIMAT0005951 hsa-miR-1307-3p -6.19 5.25e-09 -0.34 -0.45 Migraine; chr10:103262005 chr10:103394301~103394322:- PAAD cis rs1712517 0.844 rs1163081 MIMAT0005951 hsa-miR-1307-3p -6.19 5.25e-09 -0.34 -0.45 Migraine; chr10:103270083 chr10:103394301~103394322:- PAAD cis rs1712517 0.844 rs1163075 MIMAT0005951 hsa-miR-1307-3p 6.19 5.25e-09 0.34 0.45 Migraine; chr10:103261506 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs2008530 MIMAT0005951 hsa-miR-1307-3p -6.18 5.55e-09 -0.34 -0.45 Migraine; chr10:103299082 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs7903004 MIMAT0005951 hsa-miR-1307-3p 6.1 8.18e-09 0.34 0.44 Migraine; chr10:103244344 chr10:103394301~103394322:- PAAD cis rs7255436 0.965 rs7254882 MIMAT0021017 hsa-miR-4999-5p 6.06 1.01e-08 0.63 0.44 HDL cholesterol; chr19:8388938 chr19:8389340~8389360:- PAAD cis rs1712517 0.566 rs1163073 MIMAT0005951 hsa-miR-1307-3p 5.96 1.7e-08 0.35 0.43 Migraine; chr10:103263177 chr10:103394301~103394322:- PAAD cis rs950880 0.71 rs1474309 MIMAT0019926 hsa-miR-4772-5p 5.95 1.79e-08 0.86 0.43 Serum protein levels (sST2); chr2:102474542 chr2:102432300~102432321:+ PAAD cis rs1712517 0.873 rs7894240 MIMAT0005951 hsa-miR-1307-3p 5.94 1.86e-08 0.33 0.43 Migraine; chr10:103240612 chr10:103394301~103394322:- PAAD cis rs7255436 0.928 rs7250870 MIMAT0021017 hsa-miR-4999-5p 5.83 3.12e-08 0.62 0.43 HDL cholesterol; chr19:8388798 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs11666233 MIMAT0021017 hsa-miR-4999-5p 5.7 5.96e-08 0.6 0.42 HDL cholesterol; chr19:8387161 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs11668346 MIMAT0021017 hsa-miR-4999-5p 5.7 5.96e-08 0.6 0.42 HDL cholesterol; chr19:8385970 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs12981318 MIMAT0021017 hsa-miR-4999-5p 5.7 5.96e-08 0.6 0.42 HDL cholesterol; chr19:8386546 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs7351098 MIMAT0021017 hsa-miR-4999-5p 5.7 5.96e-08 0.6 0.42 HDL cholesterol; chr19:8386787 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs11666003 MIMAT0021017 hsa-miR-4999-5p 5.7 5.96e-08 0.6 0.42 HDL cholesterol; chr19:8387218 chr19:8389340~8389360:- PAAD cis rs1712517 0.771 rs11191654 MIMAT0005951 hsa-miR-1307-3p -5.67 6.76e-08 -0.32 -0.42 Migraine; chr10:103317367 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs61869827 MIMAT0005951 hsa-miR-1307-3p -5.67 6.76e-08 -0.32 -0.42 Migraine; chr10:103319682 chr10:103394301~103394322:- PAAD cis rs1712517 0.844 rs4918003 MIMAT0005951 hsa-miR-1307-3p -5.67 7e-08 -0.32 -0.42 Migraine; chr10:103284400 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs7921655 MIMAT0005951 hsa-miR-1307-3p -5.66 7.22e-08 -0.31 -0.42 Migraine; chr10:103353944 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs7074749 MIMAT0005951 hsa-miR-1307-3p -5.66 7.22e-08 -0.31 -0.42 Migraine; chr10:103356299 chr10:103394301~103394322:- PAAD cis rs1712517 0.74 rs11191663 MIMAT0005951 hsa-miR-1307-3p -5.66 7.22e-08 -0.31 -0.42 Migraine; chr10:103358705 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs10883858 MIMAT0005951 hsa-miR-1307-3p -5.66 7.22e-08 -0.31 -0.42 Migraine; chr10:103367951 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs61871160 MIMAT0005951 hsa-miR-1307-3p -5.66 7.22e-08 -0.31 -0.42 Migraine; chr10:103384531 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs1163083 MIMAT0005951 hsa-miR-1307-3p -5.65 7.64e-08 -0.32 -0.42 Migraine; chr10:103278698 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191676 MIMAT0005951 hsa-miR-1307-3p -5.64 7.82e-08 -0.31 -0.42 Migraine; chr10:103395309 chr10:103394301~103394322:- PAAD cis rs7255436 0.898 rs7252574 MIMAT0021017 hsa-miR-4999-5p 5.61 9.23e-08 0.59 0.41 HDL cholesterol; chr19:8376895 chr19:8389340~8389360:- PAAD cis rs1712517 0.74 rs11191643 MIMAT0005951 hsa-miR-1307-3p -5.59 9.98e-08 -0.31 -0.41 Migraine; chr10:103297804 chr10:103394301~103394322:- PAAD cis rs7255436 0.965 rs62117510 MIMAT0021017 hsa-miR-4999-5p 5.56 1.15e-07 0.59 0.41 HDL cholesterol; chr19:8387729 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs28729307 MIMAT0021017 hsa-miR-4999-5p 5.56 1.15e-07 0.59 0.41 HDL cholesterol; chr19:8387858 chr19:8389340~8389360:- PAAD cis rs7255436 0.894 rs10413136 MIMAT0021017 hsa-miR-4999-5p 5.56 1.15e-07 0.59 0.41 HDL cholesterol; chr19:8387995 chr19:8389340~8389360:- PAAD cis rs1712517 0.835 rs2506961 MIMAT0005951 hsa-miR-1307-3p 5.54 1.28e-07 0.32 0.41 Migraine; chr10:103248169 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs1712510 MIMAT0005951 hsa-miR-1307-3p 5.54 1.28e-07 0.32 0.41 Migraine; chr10:103249329 chr10:103394301~103394322:- PAAD cis rs7255436 0.931 rs7249520 MIMAT0021017 hsa-miR-4999-5p 5.53 1.34e-07 0.59 0.41 HDL cholesterol; chr19:8381172 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs7249624 MIMAT0021017 hsa-miR-4999-5p 5.53 1.34e-07 0.59 0.41 HDL cholesterol; chr19:8381251 chr19:8389340~8389360:- PAAD cis rs7255436 0.83 rs4350678 MIMAT0021017 hsa-miR-4999-5p 5.52 1.39e-07 0.59 0.41 HDL cholesterol; chr19:8382482 chr19:8389340~8389360:- PAAD cis rs7255436 1 rs7255436 MIMAT0021017 hsa-miR-4999-5p 5.5 1.53e-07 0.59 0.41 HDL cholesterol; chr19:8368312 chr19:8389340~8389360:- PAAD cis rs7255436 0.965 rs4044435 MIMAT0021017 hsa-miR-4999-5p 5.41 2.39e-07 0.57 0.4 HDL cholesterol; chr19:8383293 chr19:8389340~8389360:- PAAD cis rs1712517 0.838 rs6584543 MIMAT0005951 hsa-miR-1307-3p 5.4 2.47e-07 0.31 0.4 Migraine; chr10:103237257 chr10:103394301~103394322:- PAAD cis rs1712517 0.74 rs4917387 MIMAT0005951 hsa-miR-1307-3p -5.38 2.73e-07 -0.3 -0.4 Migraine; chr10:103348698 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191664 MIMAT0005951 hsa-miR-1307-3p -5.38 2.73e-07 -0.3 -0.4 Migraine; chr10:103358719 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191666 MIMAT0005951 hsa-miR-1307-3p -5.38 2.73e-07 -0.3 -0.4 Migraine; chr10:103367521 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191672 MIMAT0005951 hsa-miR-1307-3p -5.38 2.73e-07 -0.3 -0.4 Migraine; chr10:103379204 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs59744322 MIMAT0005951 hsa-miR-1307-3p -5.38 2.73e-07 -0.3 -0.4 Migraine; chr10:103386935 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs2292807 MIMAT0005951 hsa-miR-1307-3p -5.37 2.93e-07 -0.3 -0.4 Migraine; chr10:103395888 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191645 MIMAT0005951 hsa-miR-1307-3p -5.34 3.33e-07 -0.3 -0.4 Migraine; chr10:103299551 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs61350103 MIMAT0005951 hsa-miR-1307-3p -5.34 3.33e-07 -0.3 -0.4 Migraine; chr10:103309363 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs1891292 MIMAT0005951 hsa-miR-1307-3p 5.27 4.66e-07 0.3 0.39 Migraine; chr10:103241753 chr10:103394301~103394322:- PAAD cis rs1712517 0.838 rs1891293 MIMAT0005951 hsa-miR-1307-3p 5.26 4.68e-07 0.31 0.39 Migraine; chr10:103242040 chr10:103394301~103394322:- PAAD cis rs7894407 0.856 rs10883855 MIMAT0005951 hsa-miR-1307-3p -5.13 8.48e-07 -0.29 -0.38 White matter hyperintensity burden; chr10:103332690 chr10:103394301~103394322:- PAAD cis rs7255436 0.965 rs2042900 MIMAT0021017 hsa-miR-4999-5p 5.12 8.95e-07 0.55 0.38 HDL cholesterol; chr19:8374818 chr19:8389340~8389360:- PAAD cis rs7894407 0.856 rs7093667 MIMAT0005951 hsa-miR-1307-3p -5.08 1.08e-06 -0.29 -0.38 White matter hyperintensity burden; chr10:103320818 chr10:103394301~103394322:- PAAD cis rs7894407 0.76 rs1163085 MIMAT0005951 hsa-miR-1307-3p -5.08 1.09e-06 -0.29 -0.38 White matter hyperintensity burden; chr10:103279484 chr10:103394301~103394322:- PAAD cis rs7829975 0.617 rs4841071 MIMAT0019728 hsa-miR-4660 5.05 1.22e-06 0.47 0.38 Mood instability; chr8:8933634 chr8:9048453~9048475:+ PAAD cis rs7829975 0.617 rs4841072 MIMAT0019728 hsa-miR-4660 -5.05 1.24e-06 -0.47 -0.38 Mood instability; chr8:8933743 chr8:9048453~9048475:+ PAAD cis rs1867631 0.959 rs11208914 MIMAT0014979 hsa-miR-3117-3p -5.01 1.52e-06 -0.5 -0.38 Menopause (age at onset); chr1:66584045 chr1:66628485~66628505:+ PAAD cis rs1867631 0.958 rs7536188 MIMAT0014979 hsa-miR-3117-3p 4.99 1.6e-06 0.5 0.37 Menopause (age at onset); chr1:66622243 chr1:66628485~66628505:+ PAAD cis rs7894407 1 rs7894407 MIMAT0005951 hsa-miR-1307-3p 4.99 1.61e-06 0.3 0.37 White matter hyperintensity burden; chr10:103416422 chr10:103394301~103394322:- PAAD cis rs1867631 1 rs6665859 MIMAT0014979 hsa-miR-3117-3p -4.99 1.61e-06 -0.5 -0.37 Menopause (age at onset); chr1:66611872 chr1:66628485~66628505:+ PAAD cis rs1867631 0.958 rs7520226 MIMAT0014979 hsa-miR-3117-3p -4.99 1.61e-06 -0.5 -0.37 Menopause (age at onset); chr1:66615312 chr1:66628485~66628505:+ PAAD cis rs1867631 1 rs7546090 MIMAT0014979 hsa-miR-3117-3p -4.99 1.61e-06 -0.5 -0.37 Menopause (age at onset); chr1:66618298 chr1:66628485~66628505:+ PAAD cis rs1867631 1 rs1867631 MIMAT0014979 hsa-miR-3117-3p -4.98 1.69e-06 -0.5 -0.37 Menopause (age at onset); chr1:66580443 chr1:66628485~66628505:+ PAAD cis rs1867631 1 rs10889636 MIMAT0014979 hsa-miR-3117-3p 4.98 1.73e-06 0.5 0.37 Menopause (age at onset); chr1:66624241 chr1:66628485~66628505:+ PAAD cis rs7829975 0.582 rs6982832 MIMAT0019728 hsa-miR-4660 -4.97 1.78e-06 -0.46 -0.37 Mood instability; chr8:8934707 chr8:9048453~9048475:+ PAAD cis rs7829975 0.582 rs6983150 MIMAT0019728 hsa-miR-4660 -4.97 1.78e-06 -0.46 -0.37 Mood instability; chr8:8934916 chr8:9048453~9048475:+ PAAD cis rs7894407 0.76 rs4917386 MIMAT0005951 hsa-miR-1307-3p 4.95 1.98e-06 0.29 0.37 White matter hyperintensity burden; chr10:103247771 chr10:103394301~103394322:- PAAD cis rs453301 0.657 rs36056437 MIMAT0019728 hsa-miR-4660 -4.94 2e-06 -0.47 -0.37 Joint mobility (Beighton score); chr8:8935355 chr8:9048453~9048475:+ PAAD cis rs1867631 1 rs11208927 MIMAT0014979 hsa-miR-3117-3p -4.94 2.06e-06 -0.49 -0.37 Menopause (age at onset); chr1:66623878 chr1:66628485~66628505:+ PAAD cis rs7894407 0.76 rs1163072 MIMAT0005951 hsa-miR-1307-3p 4.91 2.31e-06 0.28 0.37 White matter hyperintensity burden; chr10:103264621 chr10:103394301~103394322:- PAAD cis rs7894407 0.892 rs10883859 MIMAT0005951 hsa-miR-1307-3p 4.9 2.4e-06 0.29 0.37 White matter hyperintensity burden; chr10:103368377 chr10:103394301~103394322:- PAAD cis rs453301 0.598 rs2921383 MIMAT0019728 hsa-miR-4660 4.9 2.47e-06 0.44 0.37 Joint mobility (Beighton score); chr8:9034711 chr8:9048453~9048475:+ PAAD cis rs1867631 1 rs11208928 MIMAT0014979 hsa-miR-3117-3p -4.89 2.56e-06 -0.52 -0.37 Menopause (age at onset); chr1:66623879 chr1:66628485~66628505:+ PAAD cis rs1867631 0.876 rs10889637 MIMAT0014979 hsa-miR-3117-3p -4.89 2.57e-06 -0.48 -0.37 Menopause (age at onset); chr1:66631782 chr1:66628485~66628505:+ PAAD cis rs453301 0.597 rs7001187 MIMAT0019728 hsa-miR-4660 -4.8 3.73e-06 -0.46 -0.36 Joint mobility (Beighton score); chr8:8935272 chr8:9048453~9048475:+ PAAD cis rs453301 0.631 rs13250781 MIMAT0019728 hsa-miR-4660 -4.8 3.73e-06 -0.46 -0.36 Joint mobility (Beighton score); chr8:8935833 chr8:9048453~9048475:+ PAAD cis rs1712517 0.836 rs11191649 MIMAT0005951 hsa-miR-1307-3p -4.8 3.8e-06 -0.28 -0.36 Migraine; chr10:103307280 chr10:103394301~103394322:- PAAD cis rs453301 0.631 rs28572014 MIMAT0019728 hsa-miR-4660 -4.77 4.35e-06 -0.46 -0.36 Joint mobility (Beighton score); chr8:8936097 chr8:9048453~9048475:+ PAAD cis rs453301 0.624 rs2979265 MIMAT0019728 hsa-miR-4660 4.76 4.51e-06 0.44 0.36 Joint mobility (Beighton score); chr8:9001207 chr8:9048453~9048475:+ PAAD cis rs1867631 1 rs10889640 MIMAT0014979 hsa-miR-3117-3p -4.73 5.14e-06 -0.49 -0.36 Menopause (age at onset); chr1:66662168 chr1:66628485~66628505:+ PAAD cis rs1867631 1 rs10789212 MIMAT0014979 hsa-miR-3117-3p -4.73 5.14e-06 -0.49 -0.36 Menopause (age at onset); chr1:66662472 chr1:66628485~66628505:+ PAAD cis rs1867631 1 rs10789213 MIMAT0014979 hsa-miR-3117-3p -4.73 5.14e-06 -0.49 -0.36 Menopause (age at onset); chr1:66662518 chr1:66628485~66628505:+ PAAD cis rs453301 0.631 rs17700611 MIMAT0019728 hsa-miR-4660 -4.7 5.71e-06 -0.46 -0.36 Joint mobility (Beighton score); chr8:8936144 chr8:9048453~9048475:+ PAAD cis rs1712517 0.904 rs7905968 MIMAT0005951 hsa-miR-1307-3p -4.69 6e-06 -0.28 -0.35 Migraine; chr10:103375562 chr10:103394301~103394322:- PAAD cis rs1712517 0.836 rs7093039 MIMAT0005951 hsa-miR-1307-3p -4.69 6e-06 -0.28 -0.35 Migraine; chr10:103389790 chr10:103394301~103394322:- PAAD cis rs453301 0.631 rs7843369 MIMAT0019728 hsa-miR-4660 -4.69 6.03e-06 -0.45 -0.35 Joint mobility (Beighton score); chr8:8940276 chr8:9048453~9048475:+ PAAD cis rs453301 0.631 rs11779804 MIMAT0019728 hsa-miR-4660 -4.69 6.03e-06 -0.45 -0.35 Joint mobility (Beighton score); chr8:8940442 chr8:9048453~9048475:+ PAAD cis rs1712517 0.771 rs10883857 MIMAT0005951 hsa-miR-1307-3p 4.69 6.05e-06 0.27 0.35 Migraine; chr10:103367830 chr10:103394301~103394322:- PAAD cis rs453301 0.624 rs6987558 MIMAT0019728 hsa-miR-4660 4.66 6.78e-06 0.43 0.35 Joint mobility (Beighton score); chr8:9005011 chr8:9048453~9048475:+ PAAD cis rs453301 0.579 rs10096850 MIMAT0019728 hsa-miR-4660 -4.65 7.02e-06 -0.45 -0.35 Joint mobility (Beighton score); chr8:8940712 chr8:9048453~9048475:+ PAAD cis rs7829975 0.582 rs448231 MIMAT0019728 hsa-miR-4660 -4.63 7.67e-06 -0.43 -0.35 Mood instability; chr8:8932549 chr8:9048453~9048475:+ PAAD cis rs1712517 1 rs1163084 MIMAT0005951 hsa-miR-1307-3p -4.62 8.12e-06 -0.27 -0.35 Migraine; chr10:103279291 chr10:103394301~103394322:- PAAD cis rs1712517 0.787 rs1163089 MIMAT0022727 hsa-miR-1307-5p -4.62 8.17e-06 -0.38 -0.35 Migraine; chr10:103284207 chr10:103394341~103394361:- PAAD cis rs1712517 1 rs3123794 MIMAT0005951 hsa-miR-1307-3p -4.61 8.38e-06 -0.27 -0.35 Migraine; chr10:103273985 chr10:103394301~103394322:- PAAD cis rs7829975 0.606 rs6422352 MIMAT0019728 hsa-miR-4660 -4.61 8.4e-06 -0.44 -0.35 Mood instability; chr8:8936683 chr8:9048453~9048475:+ PAAD cis rs7829975 0.606 rs891570 MIMAT0019728 hsa-miR-4660 -4.61 8.4e-06 -0.44 -0.35 Mood instability; chr8:8936944 chr8:9048453~9048475:+ PAAD cis rs7829975 0.606 rs10112585 MIMAT0019728 hsa-miR-4660 -4.61 8.59e-06 -0.44 -0.35 Mood instability; chr8:8937520 chr8:9048453~9048475:+ PAAD cis rs7829975 0.606 rs11776838 MIMAT0019728 hsa-miR-4660 -4.6 8.64e-06 -0.44 -0.35 Mood instability; chr8:8937291 chr8:9048453~9048475:+ PAAD cis rs75358501 0.901 rs17212861 MIMAT0014995 hsa-miR-3130-5p -4.6 8.68e-06 -0.74 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206725849 chr2:206783276~206783296:- PAAD cis rs75358501 0.901 rs17212861 MIMAT0014995_1 hsa-miR-3130-5p -4.6 8.68e-06 -0.74 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206725849 chr2:206783246~206783266:+ PAAD cis rs75358501 0.901 rs115783504 MIMAT0014995 hsa-miR-3130-5p -4.6 8.68e-06 -0.74 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206725950 chr2:206783276~206783296:- PAAD cis rs75358501 0.901 rs115783504 MIMAT0014995_1 hsa-miR-3130-5p -4.6 8.68e-06 -0.74 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206725950 chr2:206783246~206783266:+ PAAD cis rs7829975 0.572 rs7005000 MIMAT0019728 hsa-miR-4660 -4.6 8.69e-06 -0.44 -0.35 Mood instability; chr8:8939092 chr8:9048453~9048475:+ PAAD cis rs1712517 0.844 rs1163087 MIMAT0022727 hsa-miR-1307-5p -4.6 8.76e-06 -0.38 -0.35 Migraine; chr10:103283532 chr10:103394341~103394361:- PAAD cis rs453301 0.605 rs7843024 MIMAT0019728 hsa-miR-4660 -4.59 8.99e-06 -0.46 -0.35 Joint mobility (Beighton score); chr8:8942466 chr8:9048453~9048475:+ PAAD cis rs453301 0.631 rs7843789 MIMAT0019728 hsa-miR-4660 -4.59 8.99e-06 -0.46 -0.35 Joint mobility (Beighton score); chr8:8943051 chr8:9048453~9048475:+ PAAD cis rs453301 0.631 rs4840376 MIMAT0019728 hsa-miR-4660 -4.59 8.99e-06 -0.46 -0.35 Joint mobility (Beighton score); chr8:8944591 chr8:9048453~9048475:+ PAAD cis rs1712517 0.904 rs4918007 MIMAT0005951 hsa-miR-1307-3p 4.57 9.84e-06 0.27 0.35 Migraine; chr10:103347713 chr10:103394301~103394322:- PAAD cis rs1712517 0.904 rs6584547 MIMAT0005951 hsa-miR-1307-3p -4.56 1.05e-05 -0.27 -0.35 Migraine; chr10:103305652 chr10:103394301~103394322:- PAAD cis rs453301 0.631 rs11780774 MIMAT0019728 hsa-miR-4660 -4.53 1.17e-05 -0.46 -0.34 Joint mobility (Beighton score); chr8:8941601 chr8:9048453~9048475:+ PAAD cis rs1712517 0.904 rs10883863 MIMAT0005951 hsa-miR-1307-3p 4.53 1.18e-05 0.27 0.34 Migraine; chr10:103402122 chr10:103394301~103394322:- PAAD cis rs75358501 0.901 rs16838691 MIMAT0014995 hsa-miR-3130-5p -4.53 1.2e-05 -0.6 -0.34 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206718128 chr2:206783276~206783296:- PAAD cis rs75358501 0.901 rs16838691 MIMAT0014995_1 hsa-miR-3130-5p -4.53 1.2e-05 -0.6 -0.34 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206718128 chr2:206783246~206783266:+ PAAD cis rs7894407 0.504 rs7089271 MIMAT0005951 hsa-miR-1307-3p -4.53 1.2e-05 -0.27 -0.34 White matter hyperintensity burden; chr10:103417157 chr10:103394301~103394322:- PAAD cis rs7829975 0.567 rs6601273 MIMAT0019728 hsa-miR-4660 -4.5 1.31e-05 -0.43 -0.34 Mood instability; chr8:8939009 chr8:9048453~9048475:+ PAAD cis rs7829975 0.606 rs7819827 MIMAT0019728 hsa-miR-4660 -4.5 1.31e-05 -0.43 -0.34 Mood instability; chr8:8939545 chr8:9048453~9048475:+ PAAD cis rs7829975 0.509 rs7838674 MIMAT0019728 hsa-miR-4660 -4.5 1.31e-05 -0.43 -0.34 Mood instability; chr8:8939563 chr8:9048453~9048475:+ PAAD cis rs7829975 0.573 rs7842359 MIMAT0019728 hsa-miR-4660 -4.5 1.31e-05 -0.43 -0.34 Mood instability; chr8:8939568 chr8:9048453~9048475:+ PAAD cis rs1964356 0.524 rs7839585 MIMAT0019728 hsa-miR-4660 -4.5 1.32e-05 -0.44 -0.34 Mean corpuscular volume; chr8:8996725 chr8:9048453~9048475:+ PAAD cis rs7894407 0.634 rs56060736 MIMAT0005951 hsa-miR-1307-3p 4.49 1.38e-05 0.29 0.34 White matter hyperintensity burden; chr10:103310496 chr10:103394301~103394322:- PAAD cis rs1712517 0.873 rs1712516 MIMAT0022727 hsa-miR-1307-5p -4.49 1.38e-05 -0.36 -0.34 Migraine; chr10:103273871 chr10:103394341~103394361:- PAAD cis rs453301 0.598 rs10104303 MIMAT0019728 hsa-miR-4660 4.49 1.39e-05 0.4 0.34 Joint mobility (Beighton score); chr8:8977018 chr8:9048453~9048475:+ PAAD cis rs1712517 0.873 rs1163086 MIMAT0022727 hsa-miR-1307-5p -4.48 1.43e-05 -0.36 -0.34 Migraine; chr10:103279822 chr10:103394341~103394361:- PAAD cis rs4547160 0.962 rs12229749 MIMAT0004585 hsa-let-7i-3p -4.47 1.49e-05 -0.32 -0.34 Morning vs. evening chronotype; chr12:63109667 chr12:62603747~62603768:+ PAAD cis rs453301 0.624 rs2288671 MIMAT0019728 hsa-miR-4660 4.45 1.65e-05 0.41 0.34 Joint mobility (Beighton score); chr8:9003384 chr8:9048453~9048475:+ PAAD cis rs453301 0.598 rs1025395 MIMAT0019728 hsa-miR-4660 4.45 1.67e-05 0.4 0.34 Joint mobility (Beighton score); chr8:8979093 chr8:9048453~9048475:+ PAAD cis rs7894407 0.675 rs72846190 MIMAT0005951 hsa-miR-1307-3p 4.43 1.78e-05 0.28 0.34 White matter hyperintensity burden; chr10:103319660 chr10:103394301~103394322:- PAAD cis rs1712517 1 rs1712517 MIMAT0005951 hsa-miR-1307-3p -4.42 1.86e-05 -0.26 -0.34 Migraine; chr10:103273258 chr10:103394301~103394322:- PAAD cis rs7829975 0.572 rs28730413 MIMAT0019728 hsa-miR-4660 -4.41 1.92e-05 -0.41 -0.34 Mood instability; chr8:8937937 chr8:9048453~9048475:+ PAAD cis rs453301 0.522 rs1964356 MIMAT0019728 hsa-miR-4660 4.39 2.07e-05 0.42 0.33 Joint mobility (Beighton score); chr8:8995760 chr8:9048453~9048475:+ PAAD cis rs2075671 0.818 rs10953302 MIMAT0000081 hsa-miR-25-3p 4.38 2.22e-05 0.35 0.33 Other erythrocyte phenotypes; chr7:100767944 chr7:100093571~100093592:- PAAD cis rs453301 0.624 rs4841083 MIMAT0019728 hsa-miR-4660 4.38 2.23e-05 0.41 0.33 Joint mobility (Beighton score); chr8:9012918 chr8:9048453~9048475:+ PAAD cis rs453301 0.624 rs2979256 MIMAT0019728 hsa-miR-4660 4.37 2.24e-05 0.41 0.33 Joint mobility (Beighton score); chr8:9014200 chr8:9048453~9048475:+ PAAD cis rs453301 0.653 rs7016139 MIMAT0019728 hsa-miR-4660 -4.37 2.28e-05 -0.41 -0.33 Joint mobility (Beighton score); chr8:9037960 chr8:9048453~9048475:+ PAAD cis rs453301 0.653 rs7853 MIMAT0019728 hsa-miR-4660 4.35 2.43e-05 0.41 0.33 Joint mobility (Beighton score); chr8:9033304 chr8:9048453~9048475:+ PAAD cis rs1712517 0.566 rs7076274 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103286250 chr10:103394341~103394361:- PAAD cis rs1712517 0.545 rs3740381 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103286932 chr10:103394341~103394361:- PAAD cis rs1712517 0.566 rs7917388 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103295206 chr10:103394341~103394361:- PAAD cis rs1712517 0.525 rs11191642 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103296155 chr10:103394341~103394361:- PAAD cis rs1712517 0.588 rs12220267 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103315955 chr10:103394341~103394361:- PAAD cis rs1712517 0.526 rs113528138 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103365694 chr10:103394341~103394361:- PAAD cis rs1712517 0.525 rs11191667 MIMAT0022727 hsa-miR-1307-5p -4.35 2.45e-05 -0.38 -0.33 Migraine; chr10:103369141 chr10:103394341~103394361:- PAAD cis rs1163656 0.502 rs17007711 MIMAT0003287 hsa-miR-618 4.34 2.53e-05 0.52 0.33 Dental caries; chr12:80934305 chr12:80935796~80935818:- PAAD cis rs2075671 0.818 rs10953303 MIMAT0000081 hsa-miR-25-3p 4.34 2.61e-05 0.35 0.33 Other erythrocyte phenotypes; chr7:100767990 chr7:100093571~100093592:- PAAD cis rs1964356 0.967 rs2953802 MIMAT0019728 hsa-miR-4660 4.32 2.75e-05 0.41 0.33 Mean corpuscular volume; chr8:8994371 chr8:9048453~9048475:+ PAAD cis rs7829975 0.572 rs28446104 MIMAT0019728 hsa-miR-4660 -4.32 2.77e-05 -0.41 -0.33 Mood instability; chr8:8938391 chr8:9048453~9048475:+ PAAD cis rs1712517 0.525 rs7911488 MIMAT0022727 hsa-miR-1307-5p -4.31 2.85e-05 -0.37 -0.33 Migraine; chr10:103394332 chr10:103394341~103394361:- PAAD cis rs1712517 0.524 rs1712509 MIMAT0022727 hsa-miR-1307-5p -4.3 3.03e-05 -0.37 -0.33 Migraine; chr10:103254113 chr10:103394341~103394361:- PAAD cis rs453301 0.624 rs2915251 MIMAT0019728 hsa-miR-4660 4.29 3.12e-05 0.4 0.33 Joint mobility (Beighton score); chr8:9009901 chr8:9048453~9048475:+ PAAD cis rs1712517 0.873 rs7916056 MIMAT0022727 hsa-miR-1307-5p 4.29 3.21e-05 0.35 0.33 Migraine; chr10:103238157 chr10:103394341~103394361:- PAAD cis rs7084783 0.622 rs61606504 MIMAT0005951 hsa-miR-1307-3p 4.28 3.26e-05 0.25 0.33 Fear of pain; chr10:103589010 chr10:103394301~103394322:- PAAD cis rs1712517 0.566 rs1163073 MIMAT0022727 hsa-miR-1307-5p 4.28 3.33e-05 0.38 0.33 Migraine; chr10:103263177 chr10:103394341~103394361:- PAAD cis rs1712517 0.873 rs7913461 MIMAT0022727 hsa-miR-1307-5p -4.26 3.53e-05 -0.35 -0.33 Migraine; chr10:103241568 chr10:103394341~103394361:- PAAD cis rs453301 0.653 rs1045529 MIMAT0019728 hsa-miR-4660 -4.25 3.64e-05 -0.41 -0.33 Joint mobility (Beighton score); chr8:9032588 chr8:9048453~9048475:+ PAAD cis rs730570 1 rs730570 MIMAT0003331 hsa-miR-655-3p -4.25 3.72e-05 -0.36 -0.32 Type 2 diabetes; chr14:100676553 chr14:101049610~101049631:+ PAAD cis rs453301 0.592 rs4841084 MIMAT0019728 hsa-miR-4660 4.25 3.74e-05 0.41 0.32 Joint mobility (Beighton score); chr8:9026395 chr8:9048453~9048475:+ PAAD cis rs453301 0.653 rs2956244 MIMAT0019728 hsa-miR-4660 4.25 3.74e-05 0.41 0.32 Joint mobility (Beighton score); chr8:9027656 chr8:9048453~9048475:+ PAAD cis rs453301 0.624 rs2288673 MIMAT0019728 hsa-miR-4660 4.24 3.87e-05 0.41 0.32 Joint mobility (Beighton score); chr8:9002766 chr8:9048453~9048475:+ PAAD cis rs7084783 0.6 rs11191738 MIMAT0005951 hsa-miR-1307-3p -4.24 3.91e-05 -0.25 -0.32 Fear of pain; chr10:103586227 chr10:103394301~103394322:- PAAD cis rs7084783 0.5 rs4918024 MIMAT0005951 hsa-miR-1307-3p 4.24 3.93e-05 0.26 0.32 Fear of pain; chr10:103582103 chr10:103394301~103394322:- PAAD cis rs1712517 0.525 rs2271751 MIMAT0022727 hsa-miR-1307-5p -4.23 4.01e-05 -0.37 -0.32 Migraine; chr10:103415374 chr10:103394341~103394361:- PAAD cis rs1712517 0.773 rs1063461 MIMAT0022727 hsa-miR-1307-5p -4.23 4.04e-05 -0.35 -0.32 Migraine; chr10:103289348 chr10:103394341~103394361:- PAAD cis rs1712517 0.74 rs4293062 MIMAT0022727 hsa-miR-1307-5p -4.23 4.04e-05 -0.35 -0.32 Migraine; chr10:103292867 chr10:103394341~103394361:- PAAD cis rs1712517 0.744 rs11191641 MIMAT0022727 hsa-miR-1307-5p -4.23 4.04e-05 -0.35 -0.32 Migraine; chr10:103293183 chr10:103394341~103394361:- PAAD cis rs1712517 0.744 rs4293063 MIMAT0022727 hsa-miR-1307-5p -4.23 4.04e-05 -0.35 -0.32 Migraine; chr10:103293219 chr10:103394341~103394361:- PAAD cis rs730570 0.891 rs4900470 MIMAT0003331 hsa-miR-655-3p -4.2 4.54e-05 -0.34 -0.32 Type 2 diabetes; chr14:100678359 chr14:101049610~101049631:+ PAAD cis rs12145833 0.538 rs12042959 MIMAT0019761 hsa-miR-4677-3p 4.19 4.74e-05 0.58 0.32 Obesity (early onset extreme); chr1:243369971 chr1:243346225~243346246:+ PAAD cis rs4917385 1 rs4917385 MIMAT0022727 hsa-miR-1307-5p 4.19 4.75e-05 0.36 0.32 Systemic lupus erythematosus; chr10:103243964 chr10:103394341~103394361:- PAAD cis rs7084783 0.519 rs4917395 MIMAT0005951 hsa-miR-1307-3p 4.18 4.9e-05 0.25 0.32 Fear of pain; chr10:103591625 chr10:103394301~103394322:- PAAD cis rs1712517 0.503 rs72846198 MIMAT0022727 hsa-miR-1307-5p -4.17 5.16e-05 -0.37 -0.32 Migraine; chr10:103338267 chr10:103394341~103394361:- PAAD cis rs72848980 0.582 rs4917391 MIMAT0005951 hsa-miR-1307-3p 4.17 5.18e-05 0.28 0.32 White matter hyperintensity burden; chr10:103522907 chr10:103394301~103394322:- PAAD cis rs1964356 0.967 rs17701675 MIMAT0019728 hsa-miR-4660 -4.16 5.23e-05 -0.39 -0.32 Mean corpuscular volume; chr8:8993123 chr8:9048453~9048475:+ PAAD cis rs1712517 0.771 rs7921655 MIMAT0022727 hsa-miR-1307-5p -4.15 5.54e-05 -0.35 -0.32 Migraine; chr10:103353944 chr10:103394341~103394361:- PAAD cis rs1712517 0.771 rs7074749 MIMAT0022727 hsa-miR-1307-5p -4.15 5.54e-05 -0.35 -0.32 Migraine; chr10:103356299 chr10:103394341~103394361:- PAAD cis rs1712517 0.74 rs11191663 MIMAT0022727 hsa-miR-1307-5p -4.15 5.54e-05 -0.35 -0.32 Migraine; chr10:103358705 chr10:103394341~103394361:- PAAD cis rs1712517 0.771 rs10883858 MIMAT0022727 hsa-miR-1307-5p -4.15 5.54e-05 -0.35 -0.32 Migraine; chr10:103367951 chr10:103394341~103394361:- PAAD cis rs1712517 0.771 rs61871160 MIMAT0022727 hsa-miR-1307-5p -4.15 5.54e-05 -0.35 -0.32 Migraine; chr10:103384531 chr10:103394341~103394361:- PAAD cis rs7084783 0.519 rs10879 MIMAT0005951 hsa-miR-1307-3p -4.14 5.7e-05 -0.25 -0.32 Fear of pain; chr10:103594799 chr10:103394301~103394322:- PAAD cis rs1712517 0.771 rs11191676 MIMAT0022727 hsa-miR-1307-5p -4.13 5.85e-05 -0.34 -0.32 Migraine; chr10:103395309 chr10:103394341~103394361:- PAAD cis rs1163656 0.502 rs10862209 MIMAT0003287 hsa-miR-618 -4.13 5.91e-05 -0.51 -0.32 Dental caries; chr12:80933176 chr12:80935796~80935818:- PAAD cis rs1163656 0.502 rs11114658 MIMAT0003287 hsa-miR-618 -4.13 5.91e-05 -0.51 -0.32 Dental caries; chr12:80933378 chr12:80935796~80935818:- PAAD cis rs7084783 0.538 rs7067892 MIMAT0005951 hsa-miR-1307-3p 4.13 5.98e-05 0.25 0.32 Fear of pain; chr10:103579941 chr10:103394301~103394322:- PAAD cis rs7084783 0.519 rs1047425 MIMAT0005951 hsa-miR-1307-3p 4.12 6.11e-05 0.25 0.32 Fear of pain; chr10:103585444 chr10:103394301~103394322:- PAAD cis rs730570 1 rs10141733 MIMAT0003331 hsa-miR-655-3p 4.11 6.41e-05 0.34 0.32 Type 2 diabetes; chr14:100676314 chr14:101049610~101049631:+ PAAD cis rs75358501 1 rs75358501 MIMAT0014995 hsa-miR-3130-5p -4.11 6.49e-05 -0.59 -0.32 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206713131 chr2:206783276~206783296:- PAAD cis rs75358501 1 rs75358501 MIMAT0014995_1 hsa-miR-3130-5p -4.11 6.49e-05 -0.59 -0.32 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206713131 chr2:206783246~206783266:+ PAAD cis rs12145833 0.679 rs12029086 MIMAT0019761 hsa-miR-4677-3p 4.11 6.53e-05 0.56 0.32 Obesity (early onset extreme); chr1:243401420 chr1:243346225~243346246:+ PAAD cis rs1867631 0.585 rs12062570 MIMAT0014979 hsa-miR-3117-3p -4.09 6.91e-05 -0.39 -0.31 Menopause (age at onset); chr1:66620602 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs4655639 MIMAT0014979 hsa-miR-3117-3p -4.09 6.91e-05 -0.39 -0.31 Menopause (age at onset); chr1:66623407 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs5008753 MIMAT0014979 hsa-miR-3117-3p -4.09 6.91e-05 -0.39 -0.31 Menopause (age at onset); chr1:66626565 chr1:66628485~66628505:+ PAAD cis rs4547160 0.962 rs7308703 MIMAT0004585 hsa-let-7i-3p -4.09 6.96e-05 -0.31 -0.31 Morning vs. evening chronotype; chr12:63101213 chr12:62603747~62603768:+ PAAD cis rs1163656 0.502 rs7310000 MIMAT0003287 hsa-miR-618 -4.09 7.07e-05 -0.52 -0.31 Dental caries; chr12:80933498 chr12:80935796~80935818:- PAAD cis rs7084783 0.519 rs2281584 MIMAT0005951 hsa-miR-1307-3p 4.08 7.29e-05 0.24 0.31 Fear of pain; chr10:103599223 chr10:103394301~103394322:- PAAD cis rs6993244 1 rs6993244 MIMAT0019728 hsa-miR-4660 4.07 7.38e-05 0.39 0.31 Mean corpuscular hemoglobin; chr8:9005549 chr8:9048453~9048475:+ PAAD cis rs7829975 0.606 rs6601274 MIMAT0019728 hsa-miR-4660 -4.07 7.44e-05 -0.39 -0.31 Mood instability; chr8:8941549 chr8:9048453~9048475:+ PAAD cis rs12145833 0.619 rs10927006 MIMAT0019761 hsa-miR-4677-3p 4.06 7.67e-05 0.56 0.31 Obesity (early onset extreme); chr1:243394357 chr1:243346225~243346246:+ PAAD cis rs1063857 0.656 rs216293 MIMAT0000617 hsa-miR-200c-3p 4.06 7.73e-05 0.21 0.31 Coagulation factor levels;vWF levels; chr12:6044493 chr12:6963742~6963764:+ PAAD cis rs453301 0.653 rs1562211 MIMAT0019728 hsa-miR-4660 -4.06 7.84e-05 -0.4 -0.31 Joint mobility (Beighton score); chr8:9044914 chr8:9048453~9048475:+ PAAD cis rs12460587 0.587 rs10415150 MIMAT0004485 hsa-let-7e-3p -4.06 7.9e-05 -0.27 -0.31 Bronchodilator response in asthma (inhaled corticosteroid treatment interaction); chr19:52101372 chr19:51692838~51692859:+ PAAD cis rs1163656 0.534 rs17007709 MIMAT0003287 hsa-miR-618 -4.05 8.07e-05 -0.44 -0.31 Dental caries; chr12:80934267 chr12:80935796~80935818:- PAAD cis rs1867631 0.585 rs9787219 MIMAT0014979 hsa-miR-3117-3p -4.05 8.08e-05 -0.38 -0.31 Menopause (age at onset); chr1:66614476 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs11208922 MIMAT0014979 hsa-miR-3117-3p -4.05 8.08e-05 -0.38 -0.31 Menopause (age at onset); chr1:66614543 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs4655642 MIMAT0014979 hsa-miR-3117-3p -4.05 8.1e-05 -0.38 -0.31 Menopause (age at onset); chr1:66624400 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs11208940 MIMAT0014979 hsa-miR-3117-3p 4.04 8.58e-05 0.39 0.31 Menopause (age at onset); chr1:66661559 chr1:66628485~66628505:+ PAAD cis rs72848980 0.582 rs72848951 MIMAT0005951 hsa-miR-1307-3p 4.03 8.82e-05 0.28 0.31 White matter hyperintensity burden; chr10:103517410 chr10:103394301~103394322:- PAAD cis rs72848980 0.582 rs72848953 MIMAT0005951 hsa-miR-1307-3p 4.03 8.82e-05 0.28 0.31 White matter hyperintensity burden; chr10:103517411 chr10:103394301~103394322:- PAAD cis rs453301 0.653 rs7005133 MIMAT0019728 hsa-miR-4660 4.03 8.92e-05 0.4 0.31 Joint mobility (Beighton score); chr8:9043712 chr8:9048453~9048475:+ PAAD cis rs453301 0.653 rs11784393 MIMAT0019728 hsa-miR-4660 4.02 9.08e-05 0.4 0.31 Joint mobility (Beighton score); chr8:9045624 chr8:9048453~9048475:+ PAAD cis rs1867631 0.585 rs12094526 MIMAT0014979 hsa-miR-3117-3p -4.02 9.19e-05 -0.38 -0.31 Menopause (age at onset); chr1:66660431 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs6670827 MIMAT0014979 hsa-miR-3117-3p -4.02 9.19e-05 -0.38 -0.31 Menopause (age at onset); chr1:66661323 chr1:66628485~66628505:+ PAAD cis rs1867631 0.585 rs6694782 MIMAT0014979 hsa-miR-3117-3p 4.02 9.19e-05 0.38 0.31 Menopause (age at onset); chr1:66661079 chr1:66628485~66628505:+ PAAD cis rs7084783 0.519 rs4918025 MIMAT0005951 hsa-miR-1307-3p 4.01 9.34e-05 0.25 0.31 Fear of pain; chr10:103583109 chr10:103394301~103394322:- PAAD cis rs8007846 0.569 rs11848463 MIMAT0004808 hsa-miR-625-3p 4.01 9.39e-05 0.29 0.31 Multiple sclerosis--Brain Glutamate Levels; chr14:65790576 chr14:65471153~65471174:+ PAAD cis rs6753739 1 rs6753739 MIMAT0014996 hsa-miR-3131 4.01 9.41e-05 0.34 0.31 Height; chr2:219164178 chr2:219058725~219058747:- PAAD cis rs1712517 0.844 rs1163075 MIMAT0022727 hsa-miR-1307-5p 4.01 9.44e-05 0.34 0.31 Migraine; chr10:103261506 chr10:103394341~103394361:- PAAD cis rs1712517 0.844 rs1163074 MIMAT0022727 hsa-miR-1307-5p -4.01 9.44e-05 -0.34 -0.31 Migraine; chr10:103262005 chr10:103394341~103394361:- PAAD cis rs1712517 0.844 rs1163081 MIMAT0022727 hsa-miR-1307-5p -4.01 9.44e-05 -0.34 -0.31 Migraine; chr10:103270083 chr10:103394341~103394361:- PAAD cis rs7829975 0.517 rs12542733 MIMAT0019728 hsa-miR-4660 -4.01 9.53e-05 -0.37 -0.31 Mood instability; chr8:8967348 chr8:9048453~9048475:+ PAAD cis rs8007846 0.569 rs11848443 MIMAT0004808 hsa-miR-625-3p -4.01 9.61e-05 -0.29 -0.31 Multiple sclerosis--Brain Glutamate Levels; chr14:65790701 chr14:65471153~65471174:+ PAAD cis rs8007846 0.569 rs11848444 MIMAT0004808 hsa-miR-625-3p -4.01 9.61e-05 -0.29 -0.31 Multiple sclerosis--Brain Glutamate Levels; chr14:65790749 chr14:65471153~65471174:+ PAAD cis rs6753739 0.826 rs6732562 MIMAT0014996 hsa-miR-3131 4 9.69e-05 0.35 0.31 Height; chr2:219102140 chr2:219058725~219058747:- PAAD cis rs1063857 0.656 rs216291 MIMAT0000617 hsa-miR-200c-3p 4 9.97e-05 0.2 0.31 Coagulation factor levels;vWF levels; chr12:6042707 chr12:6963742~6963764:+ PAAD cis rs7084783 0.519 rs10883885 MIMAT0005951 hsa-miR-1307-3p 3.99 0.000101 0.25 0.31 Fear of pain; chr10:103574095 chr10:103394301~103394322:- PAAD cis rs4547160 0.788 rs12227007 MIMAT0004585 hsa-let-7i-3p -3.99 0.000102 -0.3 -0.31 Morning vs. evening chronotype; chr12:63090930 chr12:62603747~62603768:+ PAAD cis rs7829975 0.755 rs3789849 MIMAT0019728 hsa-miR-4660 3.99 0.000102 0.39 0.31 Mood instability; chr8:8829544 chr8:9048453~9048475:+ PAAD cis rs6753739 0.871 rs6436114 MIMAT0014996 hsa-miR-3131 3.98 0.000104 0.34 0.31 Height; chr2:219138112 chr2:219058725~219058747:- PAAD cis rs6753739 0.627 rs2293070 MIMAT0014996 hsa-miR-3131 3.98 0.000106 0.34 0.31 Height; chr2:219158882 chr2:219058725~219058747:- PAAD cis rs1712517 0.771 rs2008530 MIMAT0022727 hsa-miR-1307-5p -3.97 0.000109 -0.33 -0.31 Migraine; chr10:103299082 chr10:103394341~103394361:- PAAD cis rs4547160 0.962 rs12229749 MIMAT0000415 hsa-let-7i-5p -3.97 0.000112 -0.34 -0.31 Morning vs. evening chronotype; chr12:63109667 chr12:62603691~62603712:+ PAAD cis rs6753739 0.826 rs7599778 MIMAT0014996 hsa-miR-3131 3.96 0.000114 0.35 0.31 Height; chr2:219096938 chr2:219058725~219058747:- PAAD cis rs12145833 0.679 rs10927010 MIMAT0019761 hsa-miR-4677-3p -3.96 0.000115 -0.54 -0.3 Obesity (early onset extreme); chr1:243415510 chr1:243346225~243346246:+ PAAD cis rs1712517 0.873 rs1163083 MIMAT0022727 hsa-miR-1307-5p -3.95 0.000118 -0.34 -0.3 Migraine; chr10:103278698 chr10:103394341~103394361:- PAAD cis rs6753739 0.784 rs10168527 MIMAT0014996 hsa-miR-3131 3.95 0.00012 0.34 0.3 Height; chr2:219107653 chr2:219058725~219058747:- PAAD cis rs1712517 0.844 rs4918003 MIMAT0022727 hsa-miR-1307-5p -3.95 0.000121 -0.34 -0.3 Migraine; chr10:103284400 chr10:103394341~103394361:- PAAD cis rs6753739 0.871 rs1869802 MIMAT0014996 hsa-miR-3131 3.94 0.000121 0.34 0.3 Height; chr2:219112311 chr2:219058725~219058747:- PAAD cis rs11621975 0.57 rs67941660 MIMAT0002817 hsa-miR-495-3p 3.93 0.000129 0.49 0.3 Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin; chr14:101815149 chr14:101033804~101033825:+ PAAD cis rs4934494 0.822 rs3962370 MIMAT0000104 hsa-miR-107 3.92 0.000133 0.26 0.3 Red blood cell count; chr10:89777763 chr10:89592756~89592778:- PAAD cis rs4934494 0.727 rs1590566 MIMAT0000104 hsa-miR-107 3.92 0.000133 0.26 0.3 Red blood cell count; chr10:89778781 chr10:89592756~89592778:- PAAD cis rs6753739 0.871 rs6436110 MIMAT0014996 hsa-miR-3131 3.91 0.000137 0.34 0.3 Height; chr2:219116231 chr2:219058725~219058747:- PAAD cis rs6753739 0.871 rs10932796 MIMAT0014996 hsa-miR-3131 3.91 0.000138 0.34 0.3 Height; chr2:219156790 chr2:219058725~219058747:- PAAD cis rs1712517 0.524 rs4917384 MIMAT0022727 hsa-miR-1307-5p 3.9 0.000141 0.35 0.3 Migraine; chr10:103236031 chr10:103394341~103394361:- PAAD cis rs1712517 0.771 rs11191654 MIMAT0022727 hsa-miR-1307-5p -3.9 0.000141 -0.33 -0.3 Migraine; chr10:103317367 chr10:103394341~103394361:- PAAD cis rs1712517 0.771 rs61869827 MIMAT0022727 hsa-miR-1307-5p -3.9 0.000141 -0.33 -0.3 Migraine; chr10:103319682 chr10:103394341~103394361:- PAAD cis rs1712517 0.873 rs7903004 MIMAT0022727 hsa-miR-1307-5p 3.9 0.000142 0.33 0.3 Migraine; chr10:103244344 chr10:103394341~103394361:- PAAD cis rs453301 0.652 rs2043129 MIMAT0019728 hsa-miR-4660 3.9 0.000144 0.39 0.3 Joint mobility (Beighton score); chr8:8967994 chr8:9048453~9048475:+ PAAD cis rs72848980 0.706 rs12261058 MIMAT0005951 hsa-miR-1307-3p 3.9 0.000145 0.28 0.3 White matter hyperintensity burden; chr10:103564191 chr10:103394301~103394322:- PAAD cis rs2075671 0.582 rs3891039 MIMAT0000081 hsa-miR-25-3p 3.9 0.000145 0.31 0.3 Other erythrocyte phenotypes; chr7:100749031 chr7:100093571~100093592:- PAAD cis rs453301 0.686 rs3989373 MIMAT0019728 hsa-miR-4660 -3.89 0.000146 -0.4 -0.3 Joint mobility (Beighton score); chr8:9053798 chr8:9048453~9048475:+ PAAD cis rs12145833 0.679 rs12048498 MIMAT0019761 hsa-miR-4677-3p 3.89 0.000151 0.56 0.3 Obesity (early onset extreme); chr1:243387345 chr1:243346225~243346246:+ PAAD cis rs7084783 0.507 rs10883893 MIMAT0005951 hsa-miR-1307-3p 3.89 0.000151 0.22 0.3 Fear of pain; chr10:103653885 chr10:103394301~103394322:- PAAD cis rs2075671 0.903 rs62483592 MIMAT0000081 hsa-miR-25-3p 3.88 0.000156 0.32 0.3 Other erythrocyte phenotypes; chr7:100749826 chr7:100093571~100093592:- PAAD cis rs453301 0.686 rs6601281 MIMAT0019728 hsa-miR-4660 -3.87 0.000158 -0.4 -0.3 Joint mobility (Beighton score); chr8:9053494 chr8:9048453~9048475:+ PAAD cis rs4680534 0.512 rs6441282 MIMAT0004586 hsa-miR-15b-3p -3.87 0.000159 -0.25 -0.3 Multiple sclerosis; chr3:159981289 chr3:160404645~160404666:+ PAAD cis rs6753739 0.871 rs9784128 MIMAT0014996 hsa-miR-3131 -3.87 0.000161 -0.34 -0.3 Height; chr2:219113916 chr2:219058725~219058747:- PAAD cis rs6753739 0.871 rs6436113 MIMAT0014996 hsa-miR-3131 3.87 0.000161 0.34 0.3 Height; chr2:219120176 chr2:219058725~219058747:- PAAD cis rs6753739 0.826 rs6711613 MIMAT0014996 hsa-miR-3131 3.87 0.000163 0.34 0.3 Height; chr2:219082969 chr2:219058725~219058747:- PAAD cis rs6753739 0.784 rs11690649 MIMAT0014996 hsa-miR-3131 3.87 0.000163 0.34 0.3 Height; chr2:219083049 chr2:219058725~219058747:- PAAD cis rs6753739 0.826 rs10164493 MIMAT0014996 hsa-miR-3131 3.87 0.000163 0.34 0.3 Height; chr2:219083370 chr2:219058725~219058747:- PAAD cis rs6753739 0.784 rs1378642 MIMAT0014996 hsa-miR-3131 3.87 0.000163 0.34 0.3 Height; chr2:219085388 chr2:219058725~219058747:- PAAD cis rs1712517 0.838 rs1891293 MIMAT0022727 hsa-miR-1307-5p 3.86 0.000166 0.33 0.3 Migraine; chr10:103242040 chr10:103394341~103394361:- PAAD cis rs6753739 0.745 rs7572601 MIMAT0014996 hsa-miR-3131 3.86 0.000167 0.33 0.3 Height; chr2:219154762 chr2:219058725~219058747:- PAAD cis rs12145833 0.679 rs12037698 MIMAT0019761 hsa-miR-4677-3p 3.86 0.000167 0.53 0.3 Obesity (early onset extreme); chr1:243421043 chr1:243346225~243346246:+ PAAD cis rs453301 0.686 rs6601280 MIMAT0019728 hsa-miR-4660 3.86 0.000169 0.4 0.3 Joint mobility (Beighton score); chr8:9051726 chr8:9048453~9048475:+ PAAD trans rs7874161 0.501 rs4743037 MIMAT0003241 hsa-miR-576-5p -6.31 2.91e-09 -0.58 -0.45 Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction); chr9:106877689 chr4:109488713~109488734:+ PAAD trans rs7874161 0.526 rs4743034 MIMAT0003241 hsa-miR-576-5p -6.3 3.01e-09 -0.58 -0.45 Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction); chr9:106870072 chr4:109488713~109488734:+ PAAD trans rs7027110 0.738 rs4743033 MIMAT0003241 hsa-miR-576-5p -6.15 6.37e-09 -0.61 -0.45 Height; chr9:106865632 chr4:109488713~109488734:+ PAAD trans rs7027110 0.821 rs4743035 MIMAT0003241 hsa-miR-576-5p -6.06 9.99e-09 -0.59 -0.44 Height; chr9:106875003 chr4:109488713~109488734:+ PAAD trans rs7027110 0.779 rs9299130 MIMAT0003241 hsa-miR-576-5p -6.06 9.99e-09 -0.59 -0.44 Height; chr9:106875917 chr4:109488713~109488734:+ PAAD trans rs7027110 0.779 rs4743036 MIMAT0003241 hsa-miR-576-5p -6.06 9.99e-09 -0.59 -0.44 Height; chr9:106877615 chr4:109488713~109488734:+ PAAD trans rs7027110 0.779 rs4743038 MIMAT0003241 hsa-miR-576-5p -6.06 9.99e-09 -0.59 -0.44 Height; chr9:106883706 chr4:109488713~109488734:+ PAAD trans rs7027110 0.779 rs35460589 MIMAT0003241 hsa-miR-576-5p -6.06 1.04e-08 -0.59 -0.44 Height; chr9:106882030 chr4:109488713~109488734:+ PAAD trans rs7027110 0.779 rs35699219 MIMAT0003241 hsa-miR-576-5p -6.06 1.04e-08 -0.59 -0.44 Height; chr9:106882096 chr4:109488713~109488734:+ PAAD trans rs3008870 1 rs2815371 MIMAT0004610 hsa-miR-150-3p 6.05 1.08e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67038630 chr19:49500797~49500818:- PAAD trans rs820077 0.736 rs2762336 MIMAT0015045 hsa-miR-3170 -6.05 1.09e-08 -0.82 -0.44 Systemic lupus erythematosus; chr6:35070439 chr13:98208533~98208554:+ PAAD trans rs3008870 1 rs2815357 MIMAT0004610 hsa-miR-150-3p 6.04 1.14e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67026171 chr19:49500797~49500818:- PAAD trans rs3008870 1 rs2815361 MIMAT0004610 hsa-miR-150-3p 6.04 1.14e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67028908 chr19:49500797~49500818:- PAAD trans rs3008870 1 rs2755250 MIMAT0004610 hsa-miR-150-3p 6.04 1.14e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67029600 chr19:49500797~49500818:- PAAD trans rs820077 0.61 rs2177382 MIMAT0015045 hsa-miR-3170 -6.02 1.23e-08 -0.78 -0.44 Systemic lupus erythematosus; chr6:35082729 chr13:98208533~98208554:+ PAAD trans rs3008870 1 rs2009319 MIMAT0004610 hsa-miR-150-3p 6.02 1.25e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67015387 chr19:49500797~49500818:- PAAD trans rs3008870 1 rs2755248 MIMAT0004610 hsa-miR-150-3p 6.02 1.25e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67026941 chr19:49500797~49500818:- PAAD trans rs3008870 0.883 rs2755249 MIMAT0004610 hsa-miR-150-3p 6.02 1.25e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67027979 chr19:49500797~49500818:- PAAD trans rs3008870 0.959 rs2815359 MIMAT0004610 hsa-miR-150-3p 6.02 1.25e-08 0.44 0.44 Lymphocyte percentage of white cells; chr1:67028691 chr19:49500797~49500818:- PAAD trans rs820077 0.736 rs820069 MIMAT0015045 hsa-miR-3170 -6.02 1.27e-08 -0.82 -0.44 Systemic lupus erythematosus; chr6:35072089 chr13:98208533~98208554:+ PAAD trans rs820077 0.736 rs820067 MIMAT0015045 hsa-miR-3170 -6.02 1.27e-08 -0.82 -0.44 Systemic lupus erythematosus; chr6:35072437 chr13:98208533~98208554:+ PAAD trans rs820077 0.736 rs820066 MIMAT0015045 hsa-miR-3170 -6.02 1.27e-08 -0.82 -0.44 Systemic lupus erythematosus; chr6:35072483 chr13:98208533~98208554:+ PAAD trans rs820077 0.668 rs820065 MIMAT0015045 hsa-miR-3170 -6.02 1.27e-08 -0.82 -0.44 Systemic lupus erythematosus; chr6:35072643 chr13:98208533~98208554:+